Clinical Trial Update: A Real-World Comparison of Safety and Effectiveness of Novel Oral Anti-Coagulant (NOAC) Naïve and Warfarin Naïve Non-Valvular Atrial Fibrillation (NVAF) Patients With Medicare Advantage Coverage

View source ↗

Summary

A completed real-world study comparing safety and effectiveness of NOAC-naïve versus warfarin-naïve patients with non-valvular atrial fibrillation covered by Me…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-valvular Atrial Fibrillation

Drugs mentioned

• NOACs (non-VKA oral anticoagulants) (non-vitamin K antagonist oral anticoagulants (NOACs))
• Warfarin (warfarin)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Atrial Fibrillation | Status: COMPLETED